Oral treatment with chitosan with a molecular weight approximately 105, but not its oligomer, reduced plasma content of free-radical oxidation products in normal rats and animals treated for the bone marrow form of radiation sickness and stimulated the recovery processes in involved bone marrow and peripheral blood.
View Article and Find Full Text PDF